Dominari Holdings Inc (NASDAQ: DOMH) is a financial services holding company that operates a broker-dealer and investment management businesses. Revenue comes from securities transactions, investment banking advisory fees earned on deal completion, and investment management activities conducted through registered investment adviser subsidiaries. The broker-dealer executes, settles, and finances customer and principal securities and derivative transactions on cash, margin, and delivery-versus-payment bases. On the investment management side, Dominari operates through Dominari Manager LLC and Dominari IM LLC, wholly owned subsidiaries that manage and advise the Dominari Master SPV LLC series of funds, which began raising capital from third-party investors in March 2024. As of June 17, 2025, the Company also holds a 90% membership interest in American Ventures Management LLC and American Ventures IM LLC. Investment banking revenue is contingent on successful transaction completion, creating lumpy, deal-dependent income. The filing does not disclose specific revenue figures or segment breakdowns.

Revenue model

Transactional commissions and fees from broker-dealer securities execution; contingency-based investment banking advisory fees earned only upon deal completion; investment management fees from series funds under the Dominari Master SPV LLC structure.

Products and services

Broker-dealer securities execution and settlement services; margin lending and securities financing; investment banking advisory for mergers, acquisitions, and capital markets transactions; investment management through series funds (Dominari Master SPV LLC, beginning March 2024); fund management and investment advisory via American Ventures Management LLC and American Ventures IM LLC (established June 17, 2025).

Customers and end markets

Retail brokerage customers subject to SEC Regulation Best Interest; institutional and corporate clients for investment banking transactions; third-party investors in Master SPV series funds.

Value-chain role

Broker-dealer intermediary between retail and institutional customers and capital markets; investment manager and fund sponsor for series funds; holding company dependent on subsidiary dividends and distributions for liquidity.

Geographic exposure

The filing does not disclose specific geographic revenue breakdowns. The company is incorporated in the United States and listed on the Nasdaq Capital Market under the symbol DOMH.

Source: SEC 10-K, filed 2026-03-31

Industry: Security Brokers, Dealers & Flotation Companies Peers: Achieve Life Sciences Inc Acurx Pharmaceuticals Inc SAB Biotherapeutics Inc BioCardia Inc Orgenesis Inc. Lisata Therapeutics Inc Renovacor, Inc. Corvus Pharmaceuticals Inc T2 Biosystems, Inc.